Abstract
Neurodegenerative diseases such as Alzheimer’s, Parkinson’s and Huntington disease have serious concern due to its effect on the quality of life of affected persons. They have some limitations at diagnostic as well as the treatment level. Introducing nanotechnology, for the treatment of these diseases may contribute significantly to solve the problem. There are several treatment strategies for the neurodegenerative diseases, but most of them fail to cross the Blood-Brain Barrier (BBB). The present review highlights the application of nanotechnology during last the 20 years for the treatment of neurodegenerative diseases.
Keywords: Nanotechnology, nanoparticles, neurodegenerative disease, Alzheimer's disease, Parkinson's disease, Huntington's disease.
Graphical Abstract
CNS & Neurological Disorders - Drug Targets
Title:Nanotechnology: Its Application in Treating Neurodegenerative Diseases
Volume: 20 Issue: 1
Author(s): Falaq Naz and Yasir Hasan Siddique*
Affiliation:
- Department of Zoology, Drosophila Transgenic Laboratory, Section of Genetics, Faculty of Life Sciences, Aligarh Muslim University, Aligarh-202002, Uttar Pradesh,India
Keywords: Nanotechnology, nanoparticles, neurodegenerative disease, Alzheimer's disease, Parkinson's disease, Huntington's disease.
Abstract: Neurodegenerative diseases such as Alzheimer’s, Parkinson’s and Huntington disease have serious concern due to its effect on the quality of life of affected persons. They have some limitations at diagnostic as well as the treatment level. Introducing nanotechnology, for the treatment of these diseases may contribute significantly to solve the problem. There are several treatment strategies for the neurodegenerative diseases, but most of them fail to cross the Blood-Brain Barrier (BBB). The present review highlights the application of nanotechnology during last the 20 years for the treatment of neurodegenerative diseases.
Export Options
About this article
Cite this article as:
Naz Falaq and Siddique Hasan Yasir *, Nanotechnology: Its Application in Treating Neurodegenerative Diseases, CNS & Neurological Disorders - Drug Targets 2021; 20 (1) . https://dx.doi.org/10.2174/1871527319666200916121515
DOI https://dx.doi.org/10.2174/1871527319666200916121515 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Mif1: A Missing Link between the Unfolded Protein Response Pathway and ER-Associated Protein Degradation?
Current Protein & Peptide Science Amyloid-β Immunotherapy for Alzheimers Disease
CNS & Neurological Disorders - Drug Targets Recent Developments on the Studies of Human Memapsin 2 (β-Secretase)
Current Alzheimer Research Left Ventricular Hypertrophy in Isolated Aortic Stenosis: Primetime for the Ventricle
Current Pharmaceutical Biotechnology Molecular Imaging in the Default Mode Network
Current Molecular Imaging (Discontinued) Genetics and Personalized Medicine in Antidepressant Treatment
Current Pharmaceutical Design Consensus Guideline Based Therapeutic Drug Monitoring (TDM) in Psychiatry and Neurology
Current Drug Delivery In-silico & In-vitro Identification of Structure-Activity Relationship Pattern of Serpentine & Gallic Acid Targeting PI3Kγ as Potential Anticancer Target
Current Cancer Drug Targets State of the Art Management of Transfusion-Related Acute Lung Injury (TRALI)
Current Pharmaceutical Design Commentary (Research Highlights)
CNS & Neurological Disorders - Drug Targets Herbal Medicines for the Prevention and Treatment of Alzheimer's Disease
Current Pharmaceutical Design Disaster Psychiatry: Good Intentions Seeking Science and Sustainability
Adolescent Psychiatry Auto-Contractive Maps: An Artificial Adaptive System for Data Mining. An Application to Alzheimer Disease
Current Alzheimer Research Clinical and Environmental Correlates of Serum BDNF: A Descriptive Study with Plausible Implications for AD Research
Current Alzheimer Research Recent Patents and Trends in Orally Disintegrating Tablets
Recent Patents on Drug Delivery & Formulation Recent Progress in Gene Therapy for Parkinson’s Disease
Current Molecular Medicine Link Between Chronic Bacterial Inflammation and Alzheimer Disease
CNS & Neurological Disorders - Drug Targets Hypoglycaemia and Cardiovascular Disease Risk in Patients with Diabetes
Current Pharmaceutical Design Further Vitamin D Analogs
Current Vascular Pharmacology The Paths to Neurodegeneration in Genetic Parkinson's Disease
CNS & Neurological Disorders - Drug Targets